The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
Vaccines, Blood & Biologics
Telecon, November 9, 2011 - Hemacord
BLA #: 125397
Teleconference Date: November 9, 2011
Kimberly Benton, Stephanie Simek, Mercy Quagraine, Lisa Stockbridge, Loan Nguyen
- Pablo Rubinstein, M.D. – Vice President, New York Blood Center (NYBC) and Director, National Cord Blood Program (NCBP)
- Eva Quinley – Senior Vice President (NYBC), Quality & Regulatory Affairs
- Michael Zdanowski – Director of Operations (NCBP)
- Ludy Dobrila, Ph.D. – Associate Director, Processing (NCBP)
- Andromachi Scaradavou, M.D. – Medical Director (NCBP)
- Christine Driscoll – Director, Regulatory Affairs (NYBC)
FDA and NYBC discussed text revisions needed for the Instructions for Preparation for Infusion. FDA will send revisions to NYBC after the tcon. NYBC will review and combine with the rest of the Prescribing Information, and submit to FDA.